---
$id: https://graph.org.ai/products/commodity/51182025
$type: Product
source: UNSPSC
code: "51182025"
title: "Enestebol"
class: "51182000"
classTitle: "Androgens and androgen inhibitors"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Enestebol

**UNSPSC Code**: 51182025
**Class**: [Androgens and androgen inhibitors](Androgens and androgen inhibitors.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anabolic steroid with the molecular formula C20H28O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LNS3MVH7NV, chemically known as 4,17beta-dihydroxy-17-methyl-androsta-1,4-dien-3-one, but generally known as enestebol, which bears US NIH Compound Identifier 208919. European Medicines Agency schedules Enestebol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06528MIG. The term ENESTEBOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). ENESTEBOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enestebol under HS 29372900 and SITC 54153. As of Q4 2014, ENESTEBOL remains the US FDA Preferred Term for this commodity. Enestebol bears US NLM identifiers UMLS ID C2825600 and NCI Concept Code C81377. SMILES: OC1(C2(C(C3C(CC2)C2(C(=C(O)C(=O)C=C2)CC3)C)CC1)C)C.

